Gene Therapy with Voretigene Neparvovec Improves Vision and Partially Restores Electrophysiological Function in Pre-School Children with Leber Congenital Amaurosis

Gene Therapy with Voretigene Neparvovec Improves Vision and Partially Restores Electrophysiological Function in Pre-School Children with Leber Congenital Amaurosis

Leber congenital amaurosis caused by mutations in the RPE65 gene belongs to the most severe early-onset hereditary childhood retinopathies naturally progressing to legal blindness. The novel gene therapy voretigene neparvovec is the first approved causative treatment option for this devastating eye...

Descripció completa

Dades bibliogràfiques
Autors principals: Maximilian J. Gerhardt, Claudia S. Priglinger, Günther Rudolph, Karsten Hufendiek, Carsten Framme, Herbert Jägle, Daniel J. Salchow, Andreas Anschütz, Stylianos Michalakis, Siegfried G. Priglinger
Format: Article
Idioma:English
Publicat: MDPI AG 2022-12-01
Col·lecció:Biomedicines
Matèries:
gene therapy
voretigene neparvovec
RPE65
leber congenital amaurosis
early-onset retinal dystrophy
electrophysiology
Accés en línia:https://www.mdpi.com/2227-9059/11/1/103

Internet

https://www.mdpi.com/2227-9059/11/1/103

Ítems similars